Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism GOAT inhibitors(Ghrelin O-acyltransferase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H28ClN7O2 |
InChIKeyLOOBUNKZIGSHBZ-LBPRGKRZSA-N |
CAS Registry2024569-19-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | - | 21 Aug 2016 | |
Parkinson Disease | Preclinical | - | 21 Aug 2016 |